16.2.17
Acute Exacerbation of COPD
Malawi Standard Treatment Guidelines, 6th Edition, 2023. Chapter 16, Respiratory Conditions.
Clinical Description
Acute worsening of dyspnoea, increased sputum volume, purulent sputum (+ / -fever) that requires additional treatment
- Exacerbations progression and result in loss of lung function and poor quality of life
- can be mild, moderate, or severe
Causes of exacerbations
- tracheobronchial infections main trigger - viral (rhinovirus) > bacterial (S.
pneumoniae, H. influenzae, Moraxella catarrhalis. Consider Pseudomonas aeruginosa if frequent exacerbator and recent hospital admission)
- environmental exposure / air pollution (respirable particles, ozone)
- allergens
- aspiration and GORD
- weather changes
- discontinuation of maintenance treatment
Differential diagnosis of exacerbations
- non-pulmonary infections
- pulmonary embolism
- pneumothorax
- pleural effusion
- CCF with pulmonary oedema
Investigations
- FBC, blood culture, sputum analysis, CXR
Treatment
- Exacerbations need bronchodilators, antibiotics, and steroids
- Nebulized salbutamol 5mg / ipratroprium bromide and oral aminophylline 100 mg 8 hourly PO. Can use salbutamol inhaler with spacer if no nebulised salbutamol
- Prednisolone 40 mg daily PO for 5 days (5 days course is enough).
Steroids shorten hospital stay / recovery time and improve lung function oxygenation and clinical outcome.
- Antibiotics (if bacterial infection trigger suspected)
- Amoxicillin 1g 8 hourly PO for 7 days. Alternative Amoxicillin + Clavulanic acid (AugmentinR) 625mg 8 hourly PO or doxycycline 100mg 12 hourly or azithromycin 500mg daily.
ceftriaxone 2g daily IV (if severe exacerbation) o if frequent exacerbation with recent hospital admission and antibiotic use: cover for Pseudomonas spp e.g., with ciprofloxacin 500mg 12 hourly for 7 days
- oxygen saturation and the use of oxygen
- COPD patients often have lower SpO2 than asthma patients, even when stable.
o in asthma, if SpO2 drops below 95%, it is worrisome.
o a COPD patient may be stable with SpO2 as low as 87%.
- avoid the use of high flow oxygen in COPD patients wherever possible (as oxygen may remove their hypoxia dependent respiratory drive and cause hypoventilation→ CO2 retention, narcosis → coma).
- use 2 L / min oxygen as treatment or less, or to target SpO2 to 88 - 92 %.
NIV (non-invasive ventilation) for severe exacerbation: CPAP is preferred if no contraindications
- Improves oxygenation / gas exchange / survival
- Reduce work of breathing and need for intubation
- Reduce hospital stay
- Improves respiratory acidosis
Before discharge
- start inhaled bronchodilators asap when stable before hospital discharge
- if frequent exacerbator: regular salbutal 2 puffs 6hrly through spacer
- long term use of oral steroid is not required
- plan for follow-up within 1 month: 20% of patients may not recover at 8 weeks
Check doses against the printed guideline and your clinical judgement before treating a patient. Spotted an error? Report it from the contact links below.
Need this without data?
The app holds every guideline on your device, with calculators, bookmarks and notes.